x
Filter:
Filters applied
- Oncology
- 2017 - 2022Remove 2017 - 2022 filter
Author
- Andriole, Gerald L7
- Boorjian, Stephen A7
- Daneshmand, Siamak7
- Thompson, R Houston7
- Djaladat, Hooman6
- Kim, Eric H6
- Vetter, Joel M6
- Leibovich, Bradley C5
- Shetty, Anup S5
- Kutikov, Alexander4
- Master, Viraj A4
- Abel, E Jason3
- Abouassaly, Robert3
- Assel, Melissa3
- Carroll, Peter R3
- Cher, Michael L3
- Davies, Benjamin J3
- Fam, Mina M3
- Liss, Michael A3
- Allaf, Mohamad E2
- Allen, Glenn O2
- Campbell, Steven C2
- Carter, H Ballentine2
- Chandrasekar, Thenappan2
- DeWitt-Foy, Molly E2
Keyword
- acute kidney injury1
- AKI1
- American Society of Anesthesiology1
- ASA1
- CHF1
- chronic obstructive pulmonary disease1
- CI1
- confidence interval1
- congestive heart failure1
- COPD1
- CPT1
- current procedural erminology1
- HTN1
- hypertension1
- interquartile range1
- IQR1
- length of stay1
- LOS1
- National Surgical Quality Improvement Program1
- NMIBC1
- NSQIP1
- OR1
- RF1
- TURBT1
- UTI1
Oncology
186 Results
- Oncology
The Association Between Race and 5-year Survival in Patients With Clear Cell Renal Cell Carcinoma: A Cohort Study
UrologyVol. 148p185–191Published online: December 4, 2020- Dhaval Jivanji
- Scott Jamieson
- Chase Mallory
- Vivian Wong
- Sidney Barrau
- Elias Atri
- and others
Cited in Scopus: 2To determine if race was associated with 5-year cause-specific survival in patients with clear cell renal cell carcinoma. - Oncology
Prospective Observational Study of a Racially Diverse Group of Men on Active Surveillance for Prostate Cancer
UrologyVol. 148p203–210Published online: November 6, 2020- Jacob W. Greenberg
- Gabriel Leinwand
- Allison H. Feibus
- Nora M. Haney
- L. Spencer Krane
- Raju Thomas
- and others
Cited in Scopus: 4To evaluate the risk upgrading of active surveillance (AS), we reviewed the outcomes of African American men (AA) after electing AS. AS is the standard of care for men with low-grade prostate cancer (PCa). AA are known to have more advanced PCa features and are more likely to die from PCa, thus subsequent disease progression for AA on AS is unclear. - Genomics
Hot or Not: Tumor Mutational Burden (TMB) as a Biomarker of Immunotherapy Response in Genitourinary Cancers
UrologyVol. 147p119–126Published online: October 30, 2020- Brian Halbert
- David J. Einstein
Cited in Scopus: 9Pembrolizumab was recently approved for treatment of cancers with high tumor mutational burden (TMB). We conduct a focused literature review of TMB as a predictive biomarker. TMB quantifies the sum of nonsynonymous coding mutations (typically single nucleotide substitutions and short insertion-deletions) per megabase of sequenced DNA. As a proxy for expression of immunogenic neoantigens, TMB may be an effective predictive biomarker for response to immune checkpoint inhibitors. However, like other biomarkers in this setting, TMB has many limitations; the effect of this FDA approval in the current management of genitourinary cancers is likely limited to select situations. - Oncology
Testis-sparing Surgery: A Single Institution Experience
UrologyVol. 147p192–198Published online: October 30, 2020- Jillian Egan
- Joseph G. Cheaib
- Michael J. Biles
- Mitchell M. Huang
- Meredith Metcalf
- Andres Matoso
- and others
Cited in Scopus: 4To demonstrate the safety and efficacy of testis-sparing surgery (TSS) in 2 specific circumstances: small, nonpalpable masses suspected to be benign and masses suspicious for germ cell tumor in a solitary or functionally solitary testicle or bilateral disease. - Oncology
Multiparametric Magnetic Resonance Imaging Should Be Preferred Over Digital Rectal Examination for Prostate Cancer Local Staging and Disease Risk Classification
UrologyVol. 147p205–212Published online: October 28, 2020- Timo F.W. Soeterik
- Harm H.E van Melick
- Lea M. Dijksman
- Douwe H. Biesma
- J. Alfred Witjes
- Jean-Paul A. van Basten
Cited in Scopus: 9To assess the impact of multiparametric magnetic resonance imaging (mp-MRI) local tumor staging on prostate cancer risk stratification and choice of treatment. - Oncology
A Contemporary Analysis of the 30-day Morbidity and Mortality Associated With Cytoreductive Nephrectomy
UrologyVol. 147p186–191Published online: October 23, 2020- Danica N. May
- Hayden Hill
- Marc R. Matrana
- Kathleen Lata-Arias
- Daniel J. Canter
Cited in Scopus: 3To examine the rates of adverse surgical outcomes in patients undergoing cytoreductive nephrectomy (CN) compared to patients undergoing radical nephrectomy in the nonmetastatic setting using a large administrative database. - Oncology
Early Effects of High-intensity Focused Ultrasound (HIFU) Treatment for Prostate Cancer on Fecal Continence and Anorectal Physiology
UrologyVol. 148p211–216Published online: October 16, 2020- Renato Vasconcelos Souza de Almeida
- José Ricardo Cruz Silvino
- Jamile Rosario Kalil
- Vitor Lazarini dos Santos Jr
- Vinicius Meneguette Gomes de Souza
- Jose Pontes Jr
- and others
Cited in Scopus: 0To evaluate high-intensity focused ultrasound (HIFU) effects on anorectal physiology and fecal continence or constipation, and on quality of life (QoL). - Oncology
Contemporary Trends in Presentation and Management of Spermatocytic Seminoma
UrologyVol. 146p177–182Published online: October 10, 2020- Parth M. Patel
- Hiten D. Patel
- Elizabeth L. Koehne
- Chirag Doshi
- Alex Belshoff
- Christopher M. Seffren
- and others
Cited in Scopus: 2To characterize the presentation and management of spermatocytic seminoma (SS) compared to classic seminoma in adults utilizing a large cancer registry. - Oncology
Feasibility and Outcomes of Orthotopic Ileal Neobladder Reconstruction Following Pelvic Irradiation
UrologyVol. 148p198–202Published online: September 23, 2020- April Vassantachart
- Siamak Daneshmand
- Jie Cai
- Gus Miranda
- Saum Ghodoussipour
- Anne K. Schuckman
- and others
Cited in Scopus: 1To evaluate the complications and oncologic outcomes of orthotopic ileal neobladder reconstruction (ONB) following pelvic radiotherapy (RT) compared to patients with no prior pelvic RT. - Covid-19
Association of Surgical Delay and Overall Survival in Patients With T2 Renal Masses: Implications for Critical Clinical Decision-making During the COVID-19 Pandemic
UrologyVol. 147p50–56Published online: September 20, 2020- Kevin B. Ginsburg
- Gannon L. Curtis
- Devin N. Patel
- Wen Min Chen
- Marshall C. Strother
- Alexander Kutikov
- and others
Cited in Scopus: 8To test for an association between surgical delay and overall survival (OS) for patients with T2 renal masses. Many health care systems are balancing resources to manage the current COVID-19 pandemic, which may result in surgical delay for patients with large renal masses. - Oncology
Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active Surveillance
UrologyVol. 147p213–222Published online: September 15, 2020- Kevin B Ginsburg
- Jesse C Jacobs
- Ji Qi
- Deborah R Kaye
- Susan S Eggly
- Susan M Linsell
- and others
Cited in Scopus: 5To assess the impact of confirmatory tests on active surveillance (AS) biopsy disease reclassification and progression to treatment in men with favorable risk prostate cancer (FRPC). - Oncology
Post Prostatectomy Pathologic Findings of Patients With Clinically Significant Prostate Cancer and no Significant PI-RADS Lesions on Preoperative Magnetic Resonance Imaging
UrologyVol. 146p183–188Published online: September 15, 2020- Shaheen Alanee
- Mustafa Deebajah
- Kanika Taneja
- Daniel Cole
- Milan Pantelic
- James Peabody
- and others
Cited in Scopus: 2We present postprostatectomy pathology results from a series of prostate cancer (Pca) Gleason grade group ≥2 patients who did not have findings suggestive of cancer on preoperative pelvic magnetic resonance imaging (MRI). - Oncology
Survival Outcomes in Neoadjuvant Chemotherapy for High-grade Upper Tract Urothelial Carcinoma: A Nationally Representative Analysis
UrologyVol. 146p158–167Published online: September 3, 2020- Aleem I. Khan
- Benjamin L. Taylor
- Bashir Al Hussein Al Awamlh
- Lina Posada Calderon
- Jonathan Fainberg
- Rahmi Elahjji
- and others
Cited in Scopus: 2To assess the impact of neoadjuvant chemotherapy (NAC) on survival outcomes in a contemporary cohort of patients with in upper tract urothelial carcinoma (UTUC). - Oncology
Comparison of Perioperative and Pathologic Outcomes Between Single-port and Standard Robot-assisted Radical Prostatectomy: An Analysis of a High-volume Center and the Pooled World Experience
UrologyVol. 147p223–229Published online: September 3, 2020- Mitchell M. Huang
- Hiten D. Patel
- Julia J. Wainger
- Zhuo T. Su
- Russell E.N. Becker
- Misop Han
- and others
Cited in Scopus: 8To perform an early comparative study of outcomes between single-port and robot-assisted laparoscopic radical prostatectomy (SP-RALRP) and standard RALRP at our institution and pooled analysis of series to date. - Oncology
Performance of Multiparametric MRI of the Prostate in Biopsy Naïve Men: A Meta-analysis of Prospective Studies
UrologyVol. 146p189–195Published online: September 1, 2020- Maria F. Becerra
- Mahmoud Alameddine
- Isaac Zucker
- Leonardo Tamariz
- Ana Palacio
- Zsuzsanna Nemeth
- and others
Cited in Scopus: 4To assess the outcomes through systematic review and meta-analysis of multi-parametric magnetic resonance imaging (mpMRI) of the prostate in biopsy naïve men. - Oncology
Comparison of Major Complications at 30 and 90 Days Following Radical Cystectomy
UrologyVol. 148p192–197Published online: September 1, 2020- Jacob M. Knorr
- Kyle J. Ericson
- JJ H. Zhang
- Prithvi Murthy
- Amy S. Nowacki
- Carlos Munoz-Lopez
- and others
Cited in Scopus: 7To better understand the time-course in which major complications occur after radical cystectomy and to describe associations with complications at 30 and 90 days. - Oncology
Suboptimal Prediction of Clinically Significant Prostate Cancer in Radical Prostatectomy Specimens by mpMRI-Targeted Biopsy
UrologyVol. 148p217–223Published online: August 29, 2020- Nejdet Karsiyakali
- Mahir Bulent Ozgen
- Bora Ozveren
- Cem Akbal
- Alp Dincer
- Haydar Durak
- and others
Cited in Scopus: 0To investigate the correlation of multiparametric magnetic resonance imaging targeted (TBx) and/or systematic prostate biopsy (SBx) in predicting the presence of clinically significant (cs) prostate cancer (PCa) in radical prostatectomy (RP) specimens. Concordance of mpMRI and RP specimen lesions was also investigated in terms of tumor localization and histopathological features. - Oncology
Trends in Treatment Strategies and Comparison of Outcomes in Lymph Node Positive Bladder Cancer: An Analysis of the National Cancer Database
UrologyVol. 146p168–176Published online: August 28, 2020- Christina Darwish
- Andrew Sparks
- Richard Amdur
- Akshay Reddy
- Michael Whalen
Cited in Scopus: 4To utilize a national dataset to compare outcomes and demonstrate trends in treatment for lymph node positive bladder cancer (N+ BC). - Oncology
Feasibility and Safety of Robotic Excision of Ipsilateral Retroperitoneal Recurrence After Nephrectomy for Renal Cell Carcinoma
UrologyVol. 145p159–165Published online: August 20, 2020- Rashed Ghandour
- Andre Filipe Miranda
- Nirmish Singla
- Xiaosong Meng
- Dmitry Enikeev
- Solomon Woldu
- and others
Cited in Scopus: 2To determine feasibility and safety of robotic excision of local ipsilateral recurrences after nephrectomy for renal cell carcinoma (RCC). Surgical resection is an option for treatment of low burden locally recurrent RCC, potentially delaying the use of systemic therapy. This has historically been performed by open technique, which can impart significant morbidity. We present our experience with robotic excision. - Oncology
Contemporary Treatment Patterns for Non-muscle-invasive Bladder Cancer: Has the Use of Radical Cystectomy Changed in the BCG Shortage Era?
UrologyVol. 147p199–204Published online: August 13, 2020- Karl H. Tully
- Alexander P. Cole
- Marieke J. Krimphove
- David F. Friedlander
- Matthew Mossanen
- Peter Herzog
- and others
Cited in Scopus: 4To examine recent treatment trends for non-muscle-invasive bladder cancer (NMIBC), and specifically, to assess whether there was a change in use radical cystectomy (RC) between 2008 and 2015 using data from the Surveillance, Epidemiology, and End Results database. - Oncology
The Remaining Ipsilateral Ureteral Orifice Provokes Intravesical Tumor Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Study With a Mid-Term Follow-Up
UrologyVol. 145p166–171Published online: August 10, 2020- Se Yun Kwon
- Young Hwii Ko
- Phil Hyun Song
- Byung Hoon Kim
- Bum Soo Kim
- Tae-Hwan Kim
- and others
Cited in Scopus: 1To investigate the impact of the remnant ureteral orifice (RUO) on the prognosis of upper tract urothelial carcinoma (UTUC), because the presence of an ipsilateral intact ureteral orifice is not an uncommon finding during follow-up cystoscopy despite the clinical relevance of bladder cuffing during radical nephroureterectomy (RNU) for the management of UTUC. - Oncology
Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma
UrologyVol. 146p152–157Published online: August 8, 2020- Leo D. Dreyfuss
- Viraj A. Master
- Jay D. Raman
- Philippe E. Spiess
- Shane A. Wells
- Suzanne B. Merrill
- and others
Cited in Scopus: 0To evaluate postoperative recurrence patterns for high-risk nonmetastatic renal cell carcinoma (RCC) and to identify prognostic factors associated with site-specific metastatic recurrence using a multi-institutional contemporary cohort. - Oncology
Overtreatment and Underutilization of Watchful Waiting in Men With Limited Life Expectancy: An Analysis of the Michigan Urological Surgery Improvement Collaborative Registry
UrologyVol. 145p190–196Published online: August 7, 2020- Udit Singhal
- Jeffrey J. Tosoian
- Ji Qi
- David C. Miller
- Susan M. Linsell
- Michael Cher
- and others
Cited in Scopus: 4To determine rates of watchful waiting (WW) vs treatment in prostate cancer (PCa) and limited life expectancy (LE) and assess determinants of management. - Oncology
Risk of Genitourinary Malignancy in the Renal Transplant Patient
UrologyVol. 145p152–158Published online: August 4, 2020- Song Jiang
- Subodh Regmi
- Scott Jackson
- Collin Calvert
- Stephanie Jarosek
- Timothy Pruett
- and others
Cited in Scopus: 3To better understand the risk of genitourinary malignancies in the renal transplant patient. Currently, no consensus exists regarding screening and intervention, with much of the clinical decision-making based on historical practices established before recent progress in immunosuppression protocols and in genitourinary cancer diagnosis and management. - Oncology
Three-tiered Subclassification System of High-risk Prostate Cancer in Men Managed With Radical Prostatectomy: Implications for Treatment Decision-making
UrologyVol. 145p197–203Published online: August 3, 2020- Nayan Lamba
- Santino Butler
- Brandon A. Mahal
- Quoc-Dien Trinh
- Brent Rose
- Martin King
- and others
Cited in Scopus: 0To inform treatment decisions for patients with high-risk prostate cancer (PCa), we determined rates of adverse pathologic factors and overall survival (OS) among subgroups of high-risk men. - Oncology
Increased Bacillus Calmette-Guérin Treatment Intensity Associated With Improved Outcomes in Elderly Patients With Non–Muscle-invasive Bladder Cancer in United States Clinical Practice
UrologyVol. 145p172–180Published online: July 24, 2020- Kyle A. Richards
- Shih-Wen Lin
- Ching-Yi Chuo
- Christina L. Derleth
- Jingbo Yi
- Marko Zivkovic
- and others
Cited in Scopus: 4To characterize Bacillus Calmette-Guérin (BCG) treatment patterns and associated outcomes in a large cohort of patients with non–muscle-invasive bladder cancer (NMIBC). - Oncology
Predictive Risk Factors for Continued Smoking after the Diagnosis of a Genitourinary Malignancy
UrologyVol. 147p178–185Published online: July 10, 2020- Mathew Q. Fakhoury
- Antoine M. Ghorayeb
- Matthew D. Houlihan
- Ryan J Powers
- Stephen Hurley
- Mark A Wille
- and others
Cited in Scopus: 0To determine risk factors for continued smoking following a diagnosis of a genitourinary (GU) malignancy. Smoking is a well established risk factor in the development of cancers involving the GU tract. Unfortunately, a large percentage of patients continue to smoke or relapse after cancer diagnosis; by doing so, there is an increased risk of recurrence, poor survival rates, treatment complications, secondary primary cancers, and other chronic smoking related illnesses. - Oncology
Treatment Outcomes in Patients With Symptomatic Lymphoceles Following Radical Prostatectomy Depend Upon Size and Presence of Infection
UrologyVol. 143p181–185Published online: June 16, 2020- Jack R. Andrews
- Ilya Sobol
- Igor Frank
- Matthew T. Gettman
- R. Houston Thompson
- R. Jeffrey Karnes
- and others
Cited in Scopus: 3To guide treatment decisions for symptomatic lymphoceles after radical prostatectomy. We examined our experience to create a treatment algorithm. - Laparoscopy and Robotics
Ambulatory Robotic-Assisted Partial Nephrectomy: Safety and Feasibility Study
UrologyVol. 143p137–141Published online: May 27, 2020- Reza Mehrazin
- Eric Bortnick
- Rollin Say
- Jared S. Winoker
Cited in Scopus: 8To evaluate the feasibility and safety of performing robotic-assisted laparoscopic partial nephrectomy (RAPN) as outpatient surgery in patients with renal masses. - Oncology
Oncological and Functional Outcomes After Organ-Sparing Plastic Reconstructive Surgery for Penile Cancer
UrologyVol. 142p161–165.e1Published online: May 5, 2020- Jaime Pérez
- Julián Chavarriaga
- Ana Ortiz
- Paola Orrego
- Sandra Rueda
- William Quiroga
- and others
Cited in Scopus: 10To describe oncological and functional outcomes in patients treated with reconstructive organ-sparing surgery (OSS) for squamous cell carcinoma of the penis. Plastic reconstructive OSS of the penis with a split thickness skin graft has been proposed as a treatment option for penile cancer, with the objective being preservation of physiological voiding and sexual function without comprising oncological control. - Oncology
Perioperative Outcome of Suprarenal Resection of Vena Cava Without Reconstruction in Urologic Malignancies: A Case Series and Review of the Literature
UrologyVol. 142p146–154Published online: April 24, 2020- Hooman Djaladat
- Alireza Ghoreifi
- Michael F. Basin
- Cory Hugen
- Mohammad Aslzare
- Gus Miranda
- and others
Cited in Scopus: 4To describe the feasibility and perioperative outcome of suprarenal resection of inferior vena cava (IVC) in urologic neoplasms without reconstruction. - Oncology
Quantifying the Relationship Between Increasing Life Expectancy and Nonprostate Cancer Mortality After Radical Prostatectomy
UrologyVol. 142p174–178Published online: April 22, 2020- Michael Froehner
- Rainer Koch
- Matthias Hübler
- Marcus Lindner
- Manfred P. Wirth
- Christian Thomas
Cited in Scopus: 1To investigate the relationship between increasing life expectancy and nonprostate cancer (competing) mortality after radical prostatectomy. - Oncology
Concordance and Performance of 4Kscore and SelectMDx for Informing Decision to Perform Prostate Biopsy and Detection of Prostate Cancer
UrologyVol. 141p119–124Published online: April 12, 2020- James Steven Wysock
- Ezequiel Becher
- Jesse Persily
- Stacy Loeb
- Herbert Lepor
Cited in Scopus: 9To compare both the concordance between the 4Kscore and SelectMDx for informing decision to perform prostate biopsy (PB) and the performance of these tests for detecting clinically significant prostate cancer (csPCa). Several biomarkers were developed to inform decisions whether to perform a PB based on the probability of detecting csPCa. There is a paucity of studies directly comparing them - Oncology
Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients With Resected, Localized Clear Cell Renal Cell Carcinoma
UrologyVol. 141p101–107Published online: April 12, 2020- Dattatraya Patil
- Thien-Linh Le
- KC Biebighauser Bens
- Mehrdad Alemozaffar
- Aaron Lay
- John Pattaras
- and others
Cited in Scopus: 3To evaluate the relationship between dynamic changes in the modified Glasgow Prognostic Scale (mGPS) and postnephrectomy survival among localized clear cell renal cell carcinoma (ccRCC) patients. - Oncology
Selective Trans-arterial Embolization of Iatrogenic Vascular Lesions Did Not Influence the Global Renal Function After Partial Nephrectomy
UrologyVol. 141p108–113Published online: April 10, 2020- Michael Baboudjian
- Bastien Gondran-Tellier
- Rony Abdallah
- Francois Lannes
- Pierre Clement Sichez
- Akram Akiki
- and others
Cited in Scopus: 3To evaluate the renal function outcomes after selective trans-arterial embolization (SAE) of iatrogenic vascular lesions (IVL), including pseudoaneurysm and arteriovenous fistula, following partial nephrectomy (PN). - Oncology
A 17-Gene Panel Genomic Prostate Score Has Similar Predictive Accuracy for Adverse Pathology at Radical Prostatectomy in African American and European American Men
UrologyVol. 142p166–173Published online: April 8, 2020- Adam B. Murphy
- Samuel Carbunaru
- Oluwarotimi S. Nettey
- Chase Gornbein
- Michael A. Dixon
- Virgilia Macias
- and others
Cited in Scopus: 7To validate the 17-gene Oncotype DX Genomic Prostate Score (GPS) as a predictor of adverse pathology (AP) in African American (AA) men and to assess the distribution of GPS in AA and European American (EA) men with localized prostate cancer. - Oncology
Reducing Readmissions Following Radical Cystectomy: Moving Beyond Enhanced Recovery
UrologyVol. 141p114–118Published online: April 6, 2020- Abhinav Khanna
- Anna Zampini
- Alice Crane
- Kyle Ericson
- Prithvi Murthy
- Michele Fascelli
- and others
Cited in Scopus: 2To assess readmission outcomes of a traditional ER pathway as well as a targeted postdischarge intervention aimed at reducing hospital readmissions following RC. - Oncology
Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical Cystectomy
UrologyVol. 140p115–121Published online: April 5, 2020- Jay Tzu-Hao Huang
- Alexander P. Cole
- Matthew Mossanen
- Mark A. Preston
- Ye Wang
- Adam S. Kibel
- and others
Cited in Scopus: 3To evaluate the impact of alvimopan in patient undergoing radical cystectomy (RC) for bladder cancer. We hypothesize that alvimopan can decrease cost for RC by reducing length of stay (LOS). - Oncology
Occult Nodal Metastases in Patients Down-Staged to Nonmuscle Invasive Disease Following Neoadjuvant Chemotherapy
UrologyVol. 142p155–160Published online: April 5, 2020- Nima Nassiri
- Saum Ghodoussipour
- Marissa Maas
- Azadeh Nazemi
- Kian Asanad
- Shane Pearce
- and others
Cited in Scopus: 5To evaluate the risk of occult nodal metastasis in patients with muscle invasive bladder cancer who exhibit a complete or partial clinical response to neoadjuvant chemotherapy (NAC) and assess a potential role for “bladder sparing” management given that the gold standard treatment, radical cystectomy (RC), is associated with high morbidity. - Oncology
Metabolic Syndrome Predicts Worse Perioperative Outcomes in Patients Treated With Partial Nephrectomy for Renal Cell Carcinoma
UrologyVol. 140p91–97Published online: March 6, 2020- Stefano Luzzago
- Carlotta Palumbo
- Giuseppe Rosiello
- Angela Pecoraro
- Marina Deuker
- Franziska Stolzenbach
- and others
Cited in Scopus: 2To test the association between metabolic syndrome (MetS) and its components (high blood pressure, body mass index [BMI] ≥ 30, altered fasting glucose, low high-density lipoprotein cholesterol and high triglycerides) on perioperative outcomes after partial nephrectomy (PN). - Oncology
Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma
UrologyVol. 140p98–106Published online: March 3, 2020- Janine Bacic
- Tao Liu
- R. Houston Thompson
- Stephen A. Boorjian
- Bradley C. Leibovich
- Dragan Golijanin
- and others
Cited in Scopus: 4To emulate two target clinical trials of radical nephrectomy (RN) with lymph node dissection (LND) vs radical nephrectomy alone. - Oncology
How the Beneficial Effects of Alvimopan Differ With Surgical Approach for Radical Cystectomy
UrologyVol. 140p107–114Published online: February 27, 2020- Kassem S. Faraj
- Nathanael Z. Judge
- Kyle M. Rose
- Sarah Eversman
- Jordan Richards
- Gail Blodgett
- and others
Cited in Scopus: 3To assess whether the beneficial perioperative effects of alvimopan differ with surgical approach for patients who undergo open radical cystectomy (ORC) vs robot-assisted radical cystectomy (RARC). - Oncology
Long-term Functional and Oncologic Outcomes of Partial Adrenalectomy for Pheochromocytoma
UrologyVol. 140p85–90Published online: February 25, 2020- Patrick T. Gomella
- Thomas H. Sanford
- Peter A. Pinto
- Gennady Bratslavsky
- Adam R. Metwalli
- W. Marston Linehan
- and others
Cited in Scopus: 9To evaluate the recurrence and functional outcomes in a primarily hereditary cohort of patients undergoing partial adrenalectomy for pheochromocytoma. - Oncology
Transperineal Free-hand mpMRI Fusion-targeted Biopsies Under Local Anesthesia: Technique and Feasibility From a Single-center Prospective Study
UrologyVol. 140p122–131Published online: February 13, 2020- Giancarlo Marra
- Alessandro Marquis
- Stefano Tappero
- Daniele D'Agate
- Marco Oderda
- Giorgio Calleris
- and others
Cited in Scopus: 13To evaluate the feasibility of “in-office” TPFBx under local anesthesia (LA). - Oncology
Simultaneous Vs Sequential Retroperitoneal, Thoracic and Cervical Resection of Post Chemotherapy Residual Masses in Patients With Metastatic Nonseminomatous Germ Cell Tumors of the Testis
UrologyVol. 138p69–76Published online: January 28, 2020- Gregory J. Nason
- Laura Donahoe
- Marc de Perrot
- Ishan Aditya
- Michael A.S. Jewett
- Philip L. Bedard
- and others
Cited in Scopus: 3To compare a simultaneous vs sequential approach to residual post chemotherapy mass resections in metastatic testis cancer. - Oncology
Evaluation of Apparent Diffusion Coefficient as a Predictor of Grade Reclassification in Men on Active Surveillance for Prostate Cancer
UrologyVol. 138p84–90Published online: January 15, 2020- Mitchell M. Huang
- Katarzyna J. Macura
- Patricia Landis
- Jonathan I. Epstein
- Rakhee Gawande
- H. Ballentine Carter
- and others
Cited in Scopus: 1To evaluate the association between apparent diffusion coefficient (ADC) on initial multiparametric MRI (mpMRI) and biopsy grade reclassification (GR) to grade group (GG) ≥2 prostate cancer (CaP) in men on active surveillance (AS) with GG 1 CaP. - Oncology
Epidural Anesthesia is Associated With Increased Complications in Cystectomy Patients: A NSQIP Analysis
UrologyVol. 138p77–83Published online: January 15, 2020- Kirtishri Mishra
- Austin Fernstrum
- Amr Mahran
- Vasu Sidagam
- Brittany Adamic
- Anjali Shekar
- and others
Cited in Scopus: 1To identify differences in short-term outcomes and readmission rates in cystectomy patients managed with general anesthesia compared to those undergoing general anesthesia and adjuvant epidural anesthesia. - Oncology
Prostate Multiparametric Magnetic Resonance Imaging Features Following Partial Gland Cryoablation
UrologyVol. 138p98–105Published online: January 15, 2020- Bashir Al Hussein Al Awamlh
- Daniel J. Margolis
- Michael D. Gross
- Shyam Natarajan
- Alan Priester
- Stefanie Hectors
- and others
Cited in Scopus: 5To assess the qualitative and quantitative changes on prostate multiparametric magnetic resonance imaging (mpMRI) following partial gland ablation (PGA) with cryotherapy and correlate with histopathology. - Health Services Research
Temporal Changes in Demographic and Clinical Characteristics of Men With Prostate Cancer Electing for Conservative Management in the United States
UrologyVol. 137p60–65Published online: January 13, 2020- Bashir Al Hussein Al Awamlh
- Xiaoyue Ma
- Douglas Scherr
- Jim C. Hu
- Jonathan E. Shoag
Cited in Scopus: 2To characterize the role of clinical and sociodemographic factors in the use of conservative management for localized prostate cancer in the US between 2010 and 2015, and to understand how those factors evolved in light of the recent national increase in conservative management rates. - Oncology
Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies
UrologyVol. 137p126–132Published online: December 30, 2019- Guillaume Ploussard
- Jean-Baptiste Beauval
- Marine Lesourd
- Christophe Almeras
- Jacques Assoun
- Richard Aziza
- and others
Cited in Scopus: 7To assess the impact of concomitant targeted biopsies (TB) for predicting final disease reclassification in MRI-positive low-risk prostate cancer patients eligible for active surveillance (AS) on systematic biopsies (SB). - Oncology
Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance Cohort
UrologyVol. 138p91–97Published online: December 30, 2019- Justin R. Gregg
- John W. Davis
- Chad Reichard
- Xuemei Wang
- Mary Achim
- Brian F. Chapin
- and others
Cited in Scopus: 3To report biopsy-related and oncologic outcomes in a large prospective active surveillance cohort that was initiated in the premagnetic resonance imaging era and to additionally identify clinical factors associated with disease reclassification in order to inform future studies designed to improve enrollment and follow-up on active surveillance. - Oncology
Risk Factors for Infection after Prostate Biopsy in the United States
UrologyVol. 138p113–118Published online: December 30, 2019- Jonathan E. Shoag
- Christopher Gaffney
- Morgan Pantuck
- Tianyi Sun
- Michael Gorin
- Edward Schaeffer
- and others
Cited in Scopus: 5We used the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked data from 2001 to 2015 and recorded 30-day infection rates and emergency department, hospital and, intensive care unit (ICU) admissions. We performed adjusted analyses to analyze the effect of age, demographic data, surgeon volume, rectal swab use, and biopsy year on infections. - Oncology
Transrectal Subharmonic Ultrasound Imaging for Prostate Cancer Detection
UrologyVol. 138p106–112Published online: December 30, 2019- I. Gupta
- B. Freid
- V. Masarapu
- P. Machado
- E. Trabulsi
- K. Wallace
- and others
Cited in Scopus: 5To assess the prostate cancer (CaP) detection rates of contrast-enhanced, transrectal subharmonic ultrasound imaging (SHI). - Health Services Research
Urinary Diversion Disparity Following Radical Cystectomy for Bladder Cancer in the Hispanic Population
UrologyVol. 137p66–71Published online: December 26, 2019- Emily M. Rios
- Mitchell A. Parma
- Roman A. Fernandez
- Timothy N. Clinton
- Ryan M. Reyes
- Dharam Kaushik
- and others
Cited in Scopus: 1To determine if disparities in quality of surgical care exist between Hispanics and non-Hispanics undergoing radical cystectomy for bladder cancer. - Oncology
DaBlaCa-11: Photodynamic Diagnosis in Flexible Cystoscopy—A Randomized Study With Focus on Recurrence
UrologyVol. 137p91–96Published online: December 13, 2019- Ditte Drejer
- Anne-Louise Moltke
- Anna Munk Nielsen
- Gitte W. Lam
- Jørgen Bjerggaard Jensen
Cited in Scopus: 9To examine whether photodynamic diagnosis (PDD) in addition to flexible cystoscopy in the outpatient clinic can reduce risk of tumor recurrence in patients with previous nonmuscle invasive bladder cancer. PDD is an optical technique that enhances the visibility of pathologic tissue and helps guidance tumor resection. - Oncology
Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria
UrologyVol. 138p60–68Published online: December 10, 2019- Zachary A. Hamilton
- Umberto Capitanio
- Deepak Pruthi
- Fady Ghali
- Alessandro Larcher
- Devin N. Patel
- and others
Cited in Scopus: 12To investigate risk factors for and outcomes in pathological T3a-upstaging in Renal Cell Carcinoma (RCC), as Tumor-Node-Metastasis staging for T3a RCC was recently revised. - Oncology
Prostate Cancer Nonascitic Peritoneal Carcinomatosis After Robot-assisted Laparoscopic Radical Prostatectomy: 3 Case Reports and Review of the Literature
UrologyVol. 137p121–125Published online: December 5, 2019- Verane Achard
- Gilles Achard
- Alex Friedlaender
- Arnaud Roth
- Jean-Christophe Tille
- Raymond Miralbell
- and others
Cited in Scopus: 9Robot-assisted laparoscopic radical prostatectomy is one of the treatment options for localized prostate cancer, with an excellent disease control rate. However, these patients can experience late disease recurrence with metastatic dissemination. Peritoneal metastases are an uncommon recurrence site. Here, we discuss 3 cases of peritoneal metastases following robot-assisted laparoscopic radical prostatectomy and the mechanisms of peritoneal invasion. Through a literature review and our case reports, we postulate the existence of 2 distinct mechanisms of peritoneal invasion: one being iatrogenic, following a laparoscopic surgery with a well differentiated prostate cancer at a nonadvanced stage of the disease, the other involving the natural course of poor-prognosis tumors, even without surgery. - Oncology
The Association of Urologic Oncology Fellowship Training and Diagnostic Yield of Prostate Biopsy
UrologyVol. 137p115–120Published online: November 27, 2019- Molly E. DeWitt-Foy
- Eric A. Klein
- Ahmed ElShafei
- W. Melissa Coronado
- Steven Campbell
- Michael Gong
- and others
Cited in Scopus: 1To determine the relationship between urologic oncology fellowship training (UOFT) and diagnostic yield of prostate biopsy. - Oncology
How Many Cores Should be Obtained During Saturation Biopsy in the Era of Multiparametric Magnetic Resonance? Experience in 875 Patients Submitted to Repeat Prostate Biopsy
UrologyVol. 137p133–137Published online: November 20, 2019- Pietro Pepe
- Michele Pennisi
- Filippo Fraggetta
Cited in Scopus: 16To evaluate the number of needle cores combined with multiparametric magnetic resonance imaging (mpMRI) findings needed to diagnose all clinically significant cases of prostate cancer (csPCa) in men subject to transperineal saturation biopsy (SPBx; 30 cores). - Oncology
Diagnostic Properties of Total and Free Prostate-Specific Antigen to Predict Overall and Clinically Significant Prostate Cancer Among Men With Low Testosterone and Prior Negative Biopsy
UrologyVol. 137p97–101Published online: November 13, 2019- Logan S. Schwarzman
- Rodrigo L. Pagani
- Samuel J. Ohlander
- Mahmoud Mima
- Michael R. Abern
- Gerald L. Andriole
- and others
Cited in Scopus: 4To evaluate whether total serum PSA, free-PSA ratio and PSA density have similar diagnostic properties for detecting prostate cancer (PCa) and clinically-significant (cs) PCa in men with normal testosterone compared to men with low testosterone with a prior negative biopsy. - OncologyOpen Access
Clinical Anatomy of the Puboprostatic Ligament for the Safe Guidance for the Prostate Surgery
UrologyVol. 136p190–195Published online: November 12, 2019- Hyun-Min Choi
- So-Young Jung
- Soo-Jung Kim
- Hee-Jun Yang
- Jang-Hwan Kim
- Young-Tae Kim
- and others
Cited in Scopus: 1To provide the anatomy of the puboprostatic ligament and related structures to save urogenital competence after prostatectomy. - Oncology
The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-Year Institutional Experience
UrologyVol. 136p169–175Published online: November 11, 2019- Andrew W. Silagy
- Roy Mano
- Kyle A. Blum
- Renzo G. DiNatale
- Julian Marcon
- Satish K. Tickoo
- and others
Cited in Scopus: 6To assess which patients respond best following cytoreductive nephrectomy for renal cell carcinoma (RCC) with sarcomatoid dedifferentiation (sRCC) and whether outcomes are improving over time. - Oncology
Redefining the Concept of Clinically Insignificant Prostate Cancer
UrologyVol. 136p176–179Published online: November 9, 2019- Daisy E. Frankcombe
- Jian Li
- Ronald J. Cohen
Cited in Scopus: 4To assess the risk of biochemical recurrence (BCR) in small low-grade prostate tumors following radical prostatectomy (RP), which are defined as clinically insignificant based on the existing criteria developed by Stamey and Epstein. - Oncology
Prostatic Ductal Adenocarcinoma Controlled for Cancer Grade and Tumor Volume Does Not Have an Independent Effect on Adverse Radical Prostatectomy Outcomes Compared to Usual Acinar Prostatic Adenocarcinoma
UrologyVol. 137p108–114Published online: November 8, 2019- Oleksii A. Iakymenko
- Isabella Lugo
- Deukwoo Kwon
- Wei Zhao
- Amin Hayee
- Sanoj Punnen
- and others
Cited in Scopus: 8To study if prostatic ductal adenocarcinoma (PDA) controlled by Grade Group (GG), PSA, and tumor volume (TV) is an independent predictor of adverse radical prostatectomy (RP) outcomes. - Oncology
UK Multicenter Prospective Evaluation of the Leibovich Score in Localized Renal Cell Carcinoma: Performance has Altered Over Time
UrologyVol. 136p162–168Published online: November 6, 2019- Naveen S. Vasudev
- Michelle Hutchinson
- Sebastian Trainor
- Roisean Ferguson
- Selina Bhattarai
- Adebanji Adeyoju
- and others
Cited in Scopus: 7To examine changes in outcome by the Leibovich score using contemporary and historic cohorts of patients presenting with renal cell carcinoma (RCC) - Oncology
Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered a “Negative Core” in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis
UrologyVol. 137p102–107Published online: November 6, 2019- Joon Yau Leong
- Jaime O. Herrera-Caceres
- Hanan Goldberg
- Elwin Tham
- Seth Teplitsky
- Leonard G. Gomella
- and others
Cited in Scopus: 0To assess the impact of excluding Gleason Grade Group 1 (GG1) prostate cancer (CaP) cores from current pre-radical prostatectomy (RP) nomograms. - Oncology
Ten-Year Treatment Outcomes of Radical Prostatectomy Vs External Beam Radiation Therapy Vs Brachytherapy for 1503 Patients With Intermediate-risk Prostate Cancer
UrologyVol. 136p180–189Published online: November 5, 2019- Barry W. Goy
- Raoul Burchette
- Margaret S. Soper
- Tangel Chang
- Harry A. Cosmatos
Cited in Scopus: 19To compare 10-year oncologic treatment outcomes of radical prostatectomy (RP) vs external beam radiation therapy (EBRT) vs brachytherapy (BT) for patients with intermediate-risk prostate cancer (IRPC). - Oncology
Percutaneous Image-guided Core Needle Biopsy for Upper Tract Urothelial Carcinoma
UrologyVol. 135p95–100Published online: October 23, 2019- Jason P. Joseph
- Theodora A. Potretzke
- Vignesh Packiam
- Vidit Sharma
- Amir Toussi
- Tanner S. Miest
- and others
Cited in Scopus: 8To better understand the safety and diagnostic yield of percutaneous core-needle biopsy (PCNB) for upper tract urothelial carcinoma (UTUC). - Oncology
The Safety and Short-term Outcomes of Leukocyte Depleted Autologous Transfusions During Radical Cystectomy
UrologyVol. 135p106–110Published online: October 16, 2019- John M Myrga
- Omar M Ayyash
- Jathin Bandari
- Mina M Fam
- Liam C Macleod
- Bruce L Jacobs
- and others
Cited in Scopus: 3To examine long- and short-term outcomes using cell salvage with a commercially available leukocyte depletion filter following radical cystectomy in an oncologic population. - Oncology
Selective Arterial Embolization for Large or Symptomatic Renal Angiomyolipoma: 10 Years of Follow-up
UrologyVol. 135p82–87Published online: October 13, 2019- Omer Anis
- Uri Rimon
- Jacob Ramon
- Boris Khaitovich
- Dorit E. Zilberman
- Orith Portnoy
- and others
Cited in Scopus: 10To assess long-term outcome after selective arterial embolization (SAE) as first-line treatment for large or symptomatic AML. - Oncology
Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery
UrologyVol. 135p88–94Published online: October 1, 2019- Daniel D. Shapiro
- Shane A. Wells
- Sara L. Best
- Sean P. Hedican
- Timothy J. Ziemlewicz
- Meghan G. Lubner
- and others
Cited in Scopus: 16To compare perioperative and oncologic outcomes for patients with clinical T1b renal cell carcinoma following treatment with microwave ablation (MW), partial nephrectomy (PN), or radical nephrectomy (RN). - Oncology
Persistent Discordance in Grade, Stage, and NCCN Risk Stratification in Men Undergoing Targeted Biopsy and Radical Prostatectomy
UrologyVol. 135p117–123Published online: September 27, 2019- Mark N. Alshak
- Neal Patel
- Michael D. Gross
- Daniel Margolis
- Jim C. Hu
Cited in Scopus: 12To elucidate the accuracy of MRI and MRI-ultrasound fusion guided targeted biopsy (TBx) on risk stratification in men who underwent subsequent radical prostatectomy (RP). - Oncology
Kidney Graft Urothelial Carcinoma: Results From a Multicentric Retrospective National Study
UrologyVol. 135p101–105Published online: September 24, 2019- Grégoire Leon
- Nicolas Szabla
- Romain Boissier
- Marc Gigante
- Kevin Caillet
- Gregory Verhoest
- and others
Cited in Scopus: 4To calculate the incidence of renal graft urothelial carcinoma in renal transplant recipients in a national large retrospective cohort and to analyze circumstances of diagnosis, treatment and outcome. - Oncology
Inferior Vena Cava Resection and Reconstruction with Bovine Pericardium for Renal Cell Carcinoma: Complications and Outcomes
UrologyVol. 134p143–147Published online: September 19, 2019- Paul David Morris
- Ruelan Furtado
- Carlo Pulitano
- Michael Crawford
- David Yeo
- Arthur Vasilaras
- and others
Cited in Scopus: 6To assess the postoperative complication rate and overall survival when bovine pericardium is used as graft material for inferior vena cava (IVC) reconstructions in patients with renal cell carcinoma (RCC). The ideal graft material is yet to be established, with synthetic grafts widely studied and used in the current literature. - Oncology
Pathological Characteristics of Prostate Cancer Occurring in Younger Men: A Retrospective Study of Prostatectomy Patients
UrologyVol. 134p163–167Published online: September 18, 2019- James Macneil
- Fiona Maclean
- Warick Delprado
Cited in Scopus: 2To determine if differences exist in the pathological characteristics of prostate cancer occurring in younger men as compared to the disease when it occurs in older men. - Oncology
Renal Mass Biopsy is Associated with Reduction in Surgery for Early-Stage Kidney Cancer
UrologyVol. 135p76–81Published online: September 16, 2019- Hiten D. Patel
- Paige E. Nichols
- Zhuo Tony Su
- Mohit Gupta
- Joseph G. Cheaib
- Mohamad E. Allaf
- and others
Cited in Scopus: 17To determine whether use of renal mass biopsy may be associated with a reduction in surgery for patients with small, localized renal cell carcinoma (cT1aN0M0), especially among older patients and patients with greater comorbidity burden. - Oncology
A New Technique in Fresh Prostate Cancer Tissue Biobanking Based on MRI-Transrectal Ultrasound Fusion Biopsy
UrologyVol. 134p186–191Published online: September 2, 2019- Changwei Ji
- Wei Wang
- Qun Lu
- Yao Fu
- Hao Jiang
- Wei Chen
- and others
Cited in Scopus: 1To present and validate a new technique for biobanking fresh-frozen prostate cancer tissue based on MRI-transrectal ultrasound fusion biopsy. - Oncology
Age Differences in Patient-reported Psychological and Physical Distress Symptoms in Bladder Cancer Patients – A Cross Sectional Study
UrologyVol. 134p154–162Published online: September 2, 2019- Rami Ajaj
- Alejandro Berlin
- Zachary Klaassen
- Thenappan Chandrasekar
- Christopher J.D. Wallis
- Ardalan E. Ahmad
- and others
Cited in Scopus: 5To assess age-based differences in psychological and physical symptoms of bladder cancer (BC) patients at different disease stages. - Oncology
Systematic Biopsy Does Not Contribute to Disease Upgrading in Patients Undergoing Targeted Biopsy for PI-RADS 5 Lesions Identified on Magnetic Resonance Imaging in the Course of Active Surveillance for Prostate Cancer
UrologyVol. 134p168–172Published online: August 31, 2019- Ahmad Arabi
- Mustafa Deebajah
- Grace Yaguchi
- Milan Pantelic
- Sean Williamson
- Nilesh Gupta
- and others
Cited in Scopus: 8To compare the utility of the systematic 12-core prostate biopsy (SB) combined with magnetic resonance imaging (MRI)-targeted lesion biopsy (MRI-TB) vs MRI-TB alone in the diagnosis of high PI-RADS lesions. - Oncology
Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma
UrologyVol. 134p148–153Published online: August 26, 2019- Leo D. Dreyfuss
- Shane A. Wells
- Sara L. Best
- Sean P. Hedican
- Timothy J. Ziemlewicz
- Meghan G. Lubner
- and others
Cited in Scopus: 5To analyze risk factors and patterns of RCC recurrence following percutaneous ablation for stage 1 tumors and develop risk-stratified follow-up imaging protocols. - Oncology
Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer
UrologyVol. 135p111–116Published online: August 24, 2019- Luke C. Peng
- Omar Y. Mian
- Pranav Lakshminarayanan
- Peng Huang
- Hee J. Bae
- Scott Robertson
- and others
Cited in Scopus: 0To explore relationships between dose to periprostatic anatomic structures and erectile dysfunction (ED) outcomes in an institutional cohort treated with prostate brachytherapy. - Oncology
Focal High-intensity Focussed Ultrasound Partial Gland Ablation for the Treatment of Localised Prostate Cancer: A Report of Medium-term Outcomes From a Single-center in the United Kingdom
UrologyVol. 133p175–181Published online: August 23, 2019- Maximilian J. Johnston
- Amr Emara
- Mohamed Noureldin
- Simon Bott
- Richard G. Hindley
Cited in Scopus: 24To report our intermediate outcomes of the use of focal ablation for treating significant unilateral prostate cancer. This technique was adopted in our center 10 years ago. With improving diagnostic accuracy of index prostate cancer lesions and a low side-effect profile, use of focal high intensity focused ultrasound (HIFU) ablation is increasing. - Oncology
Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer
UrologyVol. 133p157–163Published online: August 14, 2019- Michael Lin-Brande
- Shane M. Pearce
- Akbar N. Ashrafi
- Azadeh Nazemi
- Madeleine L. Burg
- Saum Ghodoussipour
- and others
Cited in Scopus: 7To determine if the timing of radical cystectomy for variant histology of urothelial carcinoma has an impact on survival. Variant histology has been associated with aberrant behavior compared to pure urothelial carcinoma, however the timing of surgery for these patients has not been studied. - Oncology
Diagnostic Performance of Prostate Multiparametric Magnetic Resonance Imaging in African-American Men
UrologyVol. 134p181–185Published online: August 13, 2019- Grant M. Henning
- Joel M. Vetter
- Bettina F. Drake
- Joseph E. Ippolito
- Anup S. Shetty
- Gerald L. Andriole
- and others
Cited in Scopus: 3To compare test performance of multiparametric magnetic resonance imaging (mpMRI) for detection of prostate cancer (PCa) in African-American men (AAM) and white men (WM) using the Prostate Imaging Reporting and Data System in unmatched groups as well as a cohort matched for clinical factors. - Oncology
Association Between Tumor Multifocality on Multi-parametric MRI and Detection of Clinically-Significant Prostate Cancer in Lesions with Prostate Imaging Reporting and Data System (PI-RADS) Score 4
UrologyVol. 134p173–180Published online: August 13, 2019- Kamyar Ghabili
- Matthew Swallow
- Rachael L. Sherrer
- Jamil S. Syed
- Ghazal Khajir
- Jennifer B. Gordetsky
- and others
Cited in Scopus: 2To investigate whether presence of multifocality on multi-parametric magnetic resonance imaging would increase the likelihood of detecting clinically-significant prostate cancer in a PI-RADS 4 lesion. - Oncology
Safety and Efficacy of Percutaneous Image-guided Cryoablation of Completely Endophytic Renal Masses
UrologyVol. 133p151–156Published online: August 12, 2019- Catherine A. Murray
- Brian T. Welch
- Grant D. Schmit
- John J. Schmitz
- Adam J. Weisbrod
- Matthew R. Callstrom
- and others
Cited in Scopus: 10To evaluate the safety, efficacy, and oncologic control of percutaneous image-guided cryoablation in the treatment of completely endophytic renal masses. Percutaneous image-guided cryoablation is a minimally invasive and effective treatment for small renal masses. Image-guided cryoablation is an attractive treatment for completely endophytic tumors given the challenge in visualization of such lesions during surgical extirpation. - Oncology
Chemoradiation Vs Radical Cystectomy for Muscle-invasive Bladder Cancer: A Propensity Score-weighted Comparative Analysis Using the National Cancer Database
UrologyVol. 133p164–174Published online: August 8, 2019- Dharam Kaushik
- Hanzhang Wang
- Joel Michalek
- Michael A. Liss
- Qianqian Liu
- Richa Priya Jha
- and others
Cited in Scopus: 12To address the overarching question whether chemoradiation therapy (CMT) offers overall survival (OS) similar to that of radical cystectomy (RC) in muscle-invasive bladder cancer (MIBC), we performed analyses using the National Cancer Database. - Oncology
Prostate Contrast Enhanced Transrectal Ultrasound Evaluation of the Prostate With Whole-Mount Prostatectomy Correlation
UrologyVol. 133p187–191Published online: August 1, 2019- Edouard J. Trabulsi
- Brian P. Calio
- Sarah I. Kamel
- Leonard G. Gomella
- Flemming Forsberg
- Peter McCue
- and others
Cited in Scopus: 4To investigate the diagnostic accuracy of contrast enhanced transrectal ultrasound (CE-TRUS) in comparison with whole-mount radical prostatectomy specimens. - Oncology
Long-Term Outcomes of Patients With Low Grade Cystic Renal Epithelial Neoplasms
UrologyVol. 133p145–150Published online: July 26, 2019- Mary E. Westerman
- John C. Cheville
- Christine M. Lohse
- Vidit Sharma
- Stephen A. Boorjian
- Bradley C. Leibovich
- and others
Cited in Scopus: 9To report on the long-term oncologic outcomes of 3 subtypes of low grade cystic renal epithelial neoplasms—multilocular cystic neoplasm of low malignant potential (MCLMP), cystic clear cell RCC (ccRCC), and cystic clear cell papillary RCC (ccpRCC), following 2016 reorganization by the World Health Organization. - Oncology
Nerves in the Areas Posterior to the Prostate Base Contribute to Erectile Function: An Intraoperative Electrical Stimulation Assessment
UrologyVol. 132p156–160Published online: July 12, 2019- Yasuhiro Kaiho
- Jun Ito
- Hiromichi Iwamura
- Go Anan
- Akito Kuromoto
- Tomohiro Kudo
- and others
Cited in Scopus: 3To confirm the distribution of functional nerves involved in erectile function at the posterior of the prostate base, intraoperative nerve stimulation was performed during robot-assisted radical prostatectomy (RARP) - Oncology
Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma
UrologyVol. 132p136–142Published online: July 4, 2019- Johnathan Doolittle
- Joshua Piotrowski
- Keegan Zuk
- Kenneth Jacobsohn
- Peter Langenstroer
- William See
- and others
Cited in Scopus: 19To evaluate contemporary trends in the management of small renal masses and how patient age has impacted practice patterns. - Oncology
Compliance With American Urological Association Guidelines for Nonmuscle Invasive Bladder Cancer Remains Poor: Assessing Factors Associated With Noncompliance and Survival in a Rural State
UrologyVol. 132p150–155Published online: June 25, 2019- Conrad M. Tobert
- Kenneth G. Nepple
- Bradley D. McDowell
- Mary E. Charlton
- Sarah L. Mott
- Thomas S. Gruca
- and others
Cited in Scopus: 9To identify factors associated with nonmuscle invasive bladder cancer (NMIBC) American Urological Association (AUA) guideline compliance in a rural state, to evaluate compliance rates over time, and to assess the impact of patient and provider rurality on delivery of NMIBC care. - Oncology
Impact of Neoadjuvant Chemotherapy on Concordance of PD-L1 Staining Fidelity between the Primary Tumor and Lymph Node Metastases in Bladder Cancer
UrologyVol. 131p150–156Published online: June 12, 2019- Kinnari R. Patel
- Benjamin L. Taylor
- Francesca Khani
- Thomas J. Guzzo
- Douglas S. Scherr
- Roshan Ravishankar
- and others
Cited in Scopus: 5To evaluate programmed death ligand 1 (PD-L1) staining fidelity between the primary tumor and associated lymph node metastases in bladder cancer. To secondarily evaluate whether neoadjuvant chemotherapy (NAC) affects this relationship. - Oncology
Survival Benefit Persists With Delayed Initiation of Adjuvant Chemotherapy Following Radical Cystectomy for Locally Advanced Bladder Cancer
UrologyVol. 132p143–149Published online: June 11, 2019- Christopher J. Corbett
- Leilei Xia
- Ronac Mamtani
- Stanley Bruce Malkowicz
- Thomas J. Guzzo
Cited in Scopus: 2To determine if delaying the initiation of adjuvant chemotherapy following radical cystectomy for locally advanced bladder cancer worsens overall survival. - Oncology
Clinical Characteristics and Surgical Management of Adult Adrenal Teratoma: A 15-year Experience and Systematic Review of the Literature
UrologyVol. 135p71–75Published online: June 10, 2019- Wenlong Zhong
- Runzhuo Ma
- Sida Cheng
- Jie Tian
- He Wang
- Tianyu Wang
- and others
Cited in Scopus: 5To summarize the clinical characteristics and surgical management of adrenal teratoma in adults. - Oncology
Oncological Outcome of Cytoreductive Radical Prostatectomy in Prostate Cancer Patients With Bone Oligometastases
UrologyVol. 131p166–175Published online: June 7, 2019- Tian Lan
- Ye Chen
- QinJun Su
- JianJun Ye
Cited in Scopus: 12To explore the role of cytoreductive radical prostatectomy (CRP) for locally resectable and distant oligometastatic prostate cancer (CaP). - Oncology
Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor
UrologyVol. 131p157–165Published online: May 28, 2019- Ashwin S. Balakrishnan
- Shoujun Zhao
- Janet E. Cowan
- Jeanette M. Broering
- Matthew R. Cooperberg
- Peter R. Carroll
Cited in Scopus: 4To determine trends and predictors of adjuvant therapy in patients with adverse features at radical prostatectomy (RP), and to investigate the associations of adjuvant therapy and adverse feature type with survival. - Oncology
Adoption of Abiraterone and Enzalutamide by Urologists
UrologyVol. 131p176–183Published online: May 25, 2019- Megan E.V. Caram
- Samuel R. Kaufman
- Parth K. Modi
- Lindsey Herrel
- Mary Oerline
- Ryan Ross
- and others
Cited in Scopus: 11To investigate the adoption of abiraterone and enzalutamide by urologists. Abiraterone and enzalutamide are oral therapies approved for the treatment of metastatic castration-resistant prostate cancer, a disease most commonly treated by medical oncologists. - Oncology
The Complete Spectrum of Infiltrative Renal Masses: Clinical Characteristics and Prognostic Implications
UrologyVol. 130p86–92Published online: May 7, 2019- Yanbo Wang
- Hajime Tanaka
- Yunlin Ye
- Xiaobo Ding
- Ryan D. Ward
- Rebecca A. Campbell
- and others
Cited in Scopus: 7To analyze the full spectrum of patients presenting with radiologically-identified infiltrative renal masses (IRMs), including those managed surgically or otherwise, with focus on clinical presentation/prognosis. - Oncology
Older Age at Diagnosis and Initial Disease Volume Predict Grade Reclassification Risk on Confirmatory Biopsy in Patients Considered for Active Surveillance
UrologyVol. 130p106–112Published online: May 6, 2019- Charles Dai
- Vishnu Ganesan
- Yaw A. Nyame
- Nima Almassi
- Daniel J. Greene
- Daniel Hettel
- and others
Cited in Scopus: 2To identify which active surveillance candidates benefit most from confirmatory biopsies to exclude grade underclassification.